The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide comments in response to Centers for Medicare & Medicaid Services’ (CMS) Advanced Notice of Proposed Rulemaking (ANPRM) on the Medicare Program; International Pricing Index Model for Medicare Part B Drugs; [CMS5528-ANPRM].
The Academy of Managed Care Pharmacy (AMCP) is pleased provide comments to the Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule “Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency [CMS-4187-P]” published in the Federal Register on October 18, 2018.
Press Release: The Journal of Managed Care & Specialty Pharmacy (JMCP) is pleased to announce the addition of two experienced managed care pharmacy experts to the JMCP editorial team.
December 2018 News & Views: Partnership Forum Examines Role of IDNs in Value-Based Agreements; JMCP Adds Two Editors in Response to Growing Article Submissions; AMCP Annual Meeting Registration Is Open
Leg-Reg Briefing December 2018: Advocacy on Many Fronts; 2019 State Advocacy Coordinators; Proposed Rule on Part D and Medicare Advantage; Regulations on Drug Pricing Transparency